- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2730-6011
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Natural killer cell immunotherapy in glioblastoma ; volume:13 ; number:1 ; day:28 ; month:10 ; year:2022 ; pages:1-19 ; date:12.2022
Discover oncology ; 13, Heft 1 (28.10.2022), 1-19, 12.2022
- Urheber
-
Hosseinalizadeh, Hamed
Habibi Roudkenar, Mehryar
Mohammadi Roushandeh, Amaneh
Kuwahara, Yoshikazu
Tomita, Kazuo
Sato, Tomoaki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-022-00567-1
- URN
-
urn:nbn:de:101:1-2023011321123822430989
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hosseinalizadeh, Hamed
- Habibi Roudkenar, Mehryar
- Mohammadi Roushandeh, Amaneh
- Kuwahara, Yoshikazu
- Tomita, Kazuo
- Sato, Tomoaki
- SpringerLink (Online service)
Ähnliche Objekte (12)
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Natural killer cells: a promising immunotherapy for cancer
Natural killer cell-based immunotherapy for acute myeloid leukemia
Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art